Suppr超能文献

[AMG-102通过调节c-Met/PI3K/Akt通路抑制喉鳞状细胞癌细胞的增殖并诱导其凋亡]

[AMG-102 inhibits proliferation and induces apoptosis of laryngeal squamous cell carcinoma cells by regulating c-Met/PI3K/Akt pathway].

作者信息

Cao F, Lyu X, Dong K F, Fan C, Zhang J J, Chen K, Zhang Y, Ma B J, Hou C L, Zhang C H

机构信息

Department of Radiation Oncology, the Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China.

Medical Department, Central Hospital of Baixiang County, Xingtai 055450, China.

出版信息

Zhonghua Zhong Liu Za Zhi. 2020 Feb 23;42(2):99-104. doi: 10.3760/cma.j.issn.0253-3766.2020.02.003.

Abstract

To investigate the effects of c-Met inhibitor AMG-102 on the proliferation and apoptosis of laryngeal squamous carcinoma Hep-2 cells and the underlying mechanism. Laryngeal squamous carcinoma cell line Hep-2 cells were treated with 2.5, 5 and 10 μmol/L AMG-102, respectively. The proliferation activities of Hep-2 cells were detected by 3-(4, 5-dimethyl-2-thiazolyl)-2, 5-diphenyl-2H-tetrazolium bromide (MTT). The apoptotic rate of Hep-2 cells was detected by flow cytometry analysis and Hoechst staining. The mRNA expression levels of apoptosis-related genes were detected by real-time quantitative polymerase Chain reaction (RT-qPCR), and the protein expressions of c-Met/PI3K/AKT pathway were detected by western blot. Compared with the control group, the proliferation rates of Hep-2 cells treated with 2.5, 5 and 10 μmol/L AMG-102 for 24 hours were (89.8±1.1)%, (79.8±1.0)% and (69.1±1.2)%, respectively; for 48 hours were (76.8±2.0)%, (60.2±1.1)% and (49.8±1.2)%, respectively; for 72 hours were (50.1±2.0)%, (41.5±1.1)% and (33.6±1.0), respectively, with significant differences (all <0.05). The apoptotic rates of Hep-2 cells treated with 2.5, 5 and 10 μmol/L AMG-102 for 48 hours were (16.09±1.53)%, (27.51±2.02)% and (36.57±1.42)%, respectively, which were significantly higher than (3.62±0.10) % in the control group (all <0.05). After treated with 2.5, 5 and 10 μmol/L AMG-102 for 48 hours, the relative expression levels of Bcl-2 mRNA in Hep-2 cells were 0.58±0.13, 0.38±0.12 and 0.20±0.13, respectively; the relative protein expression of p-Met were 80.0±3.8, 50.6±4.2 and 28.5±1.3, respectively; the relative protein expression of p-PI3K were 87.1±0.9, 54.2±1.2 and 21.0±1.2, respectively; the relative protein expression of p-AKT were 98.7±5.6, 56.9±3.2 and 32.2±4.3, respectively; which were significantly lower than those in the control group (all <0.05). The relative expression levels of Bax mRNA were 1.78±0.13, 2.37±0.14 and 3.05±0.13, respectively, and the relative expression levels of caspase-3 mRNA were 1.98±0.14, 2.47±0.14 and 3.15±0.13, respectively, which were significantly higher than those in the control group (all <0.05). c-Met inhibitor AMG-102 could inhibit the proliferation and induce apoptosis of laryngeal squamous carcinoma Hep-2 cells by regulating the c-Met/PI3K/Akt pathway.

摘要

探讨c-Met抑制剂AMG-102对喉鳞状细胞癌Hep-2细胞增殖和凋亡的影响及其潜在机制。分别用2.5、5和10 μmol/L AMG-102处理喉鳞状癌细胞系Hep-2细胞。采用3-(4,5-二甲基-2-噻唑基)-2,5-二苯基-2H-四氮唑溴盐(MTT)法检测Hep-2细胞的增殖活性。通过流式细胞术分析和Hoechst染色检测Hep-2细胞的凋亡率。采用实时定量聚合酶链反应(RT-qPCR)检测凋亡相关基因的mRNA表达水平,采用蛋白质免疫印迹法检测c-Met/PI3K/AKT通路的蛋白表达。与对照组相比,2.5、5和10 μmol/L AMG-102处理Hep-2细胞24小时后的增殖率分别为(89.8±1.1)%、(79.8±1.0)%和(69.1±1.2)%;处理48小时后的增殖率分别为(76.8±2.0)%、(60.2±1.1)%和(49.8±1.2)%;处理72小时后的增殖率分别为(50.1±2.0)%、(41.5±1.1)%和(33.6±1.0),差异均有统计学意义(均<0.05)。2.5、5和10 μmol/L AMG-102处理Hep-2细胞48小时后的凋亡率分别为(16.09±1.53)%、(27.51±2.02)%和(36.57±1.42)%,显著高于对照组的(3.62±0.10)%(均<0.05)。2.5、5和10 μmol/L AMG-102处理Hep-2细胞48小时后,Hep-2细胞中Bcl-2 mRNA的相对表达水平分别为0.58±0.13、0.38±0.12和0.20±0.13;p-Met的相对蛋白表达分别为80.0±3.8、50.6±4.2和28.5±1.3;p-PI3K的相对蛋白表达分别为87.1±0.9、54.2±1.2和21.0±1.2;p-AKT的相对蛋白表达分别为98.7±5.6、56.9±3.2和32.2±4.3,均显著低于对照组(均<0.05)。Bax mRNA的相对表达水平分别为1.78±0.13、2.37±0.14和3.05±0.13,caspase-3 mRNA的相对表达水平分别为1.98±0.14、2.47±0.14和3.15±0.13,均显著高于对照组(均<0.05)。c-Met抑制剂AMG-102可通过调节c-Met/PI3K/Akt通路抑制喉鳞状癌Hep-2细胞的增殖并诱导其凋亡。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验